Enhanced de novo lipogenesis in the leptin-unresponsive pancreatic islets of prediabetic Zucker diabetic fatty rats: role in the pathogenesis of lipotoxic diabetes.
Overaccumulation of fat in pancreatic islets of obese ZDF fa/fa rats is believed to cause beta-cell failure and diabetes. Previously, we demonstrated that ZDF islets have an increased capacity to esterify fatty acids imported via the circulation. Here we examine the capacity of ZDF islets to synthesize fatty acids de novo. Compared with age-matched wild-type (+/+) control islets, acetyl CoA carboxylase (ACC) mRNA was fivefold and sixfold higher and fatty acid synthetase (FAS) was fourfold and sevenfold higher in prediabetic and diabetic ZDF islets, respectively. Incorporation of label from [14C]glucose into lipids was 84% higher in ZDF islets and was not suppressed normally by fatty acids. Chronic hyperleptinemia, induced by adenoviral transfer of leptin cDNA, reduced ACC and FAS mRNA in +/+ islets by 93 and 80%, respectively, but did not decrease the high ACC and FAS expression in islets of fa/fa rats. Recombinant leptin cultured with islets isolated from +/+ rats lowered ACC and FAS expression by 66 and 47%, respectively, but had no effect in fa/fa islets. We conclude that de novo lipogenesis in islets is controlled by leptin and remains low in leptin-responsive islets. It is increased in leptin-insensitive fa/fa islets, contributing to the fat overload that leads to beta-cell dysfunction and diabetes.
Zhou
Y T
YT
Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas 75235-8854, USA.
Shimabukuro
M
M
Lee
Y
Y
Koyama
K
K
Higa
M
M
Ferguson
T
T
Unger
R H
RH
D000103:Acetyl-CoA Carboxylase / Q000235:genetics; D000818:Animals; D003920:Diabetes Mellitus / Q000201:enzymology / Q000209:etiology / Q000235:genetics; D064429:Fatty Acid Synthases / Q000235:genetics; D005230:Fatty Acids, Nonesterified / Q000494:pharmacology; D005260:Female; D015870:Gene Expression / Q000187:drug effects; D015971:Gene Expression Regulation, Enzymologic; D005947:Glucose / Q000378:metabolism; D007515:Islets of Langerhans / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D020738:Leptin; D008055:Lipids / Q000096:biosynthesis* / Q000502:physiology; D008297:Male; D009765:Obesity / Q000235:genetics; D011236:Prediabetic State / Q000201:enzymology / Q000209:etiology / Q000235:genetics; D011506:Proteins / Q000235:genetics / Q000494:pharmacology*; D012333:RNA, Messenger / Q000378:metabolism; D051381:Rats; D011924:Rats, Zucker; D011993:Recombinant Fusion Proteins / Q000235:genetics / Q000494:pharmacology
D005230:Fatty Acids, Nonesterified; D020738:Leptin; D008055:Lipids; D011506:Proteins; D012333:RNA, Messenger; D011993:Recombinant Fusion Proteins; D064429:Fatty Acid Synthases; D000103:Acetyl-CoA Carboxylase; D005947:Glucose